1043961--3/30/2009--TRANSGENOMIC_INC

related topics
{property, intellectual, protect}
{stock, price, share}
{customer, product, revenue}
{cost, regulation, environmental}
{condition, economic, financial}
{operation, international, foreign}
{acquisition, growth, future}
{control, financial, internal}
{personnel, key, retain}
{competitive, industry, competition}
We may not have adequate financial resources to execute our business plan. We have a history of operating losses and may incur losses in the future. Market demand is outside of our control. The current economy may decrease sales. Sales of our Laboratory Services have been variable. Compliance with HIPAA is time consuming and costly. The sale of our products and business operations in international markets subjects us to additional risks. Our WAVE System includes hardware components and instrumentation manufactured by a single supplier and if we are no longer able to obtain these components and instrumentation our ability to manufacture our products could be impaired. The current economy may cause suppliers of products to not be able to perform. We may not have adequate personnel to execute our business plan. Our markets are very competitive. Our patents may not protect us from others using our technology that could harm our business and competitive position. We cannot be certain that other measures taken to protect our intellectual property will be effective. We are dependent upon our licensed technologies and may need to obtain additional licenses in the future to offer our products and remain competitive. The protection of intellectual property in foreign countries is uncertain. Our products could infringe on the intellectual property rights of others. Our failure to comply with any applicable government regulations or otherwise respond to claims relating to improper handling, storage or disposal of hazardous chemicals that we use may adversely affect our results of operations. The price for our common stock is volatile and may drop. Our stock has been delisted from the Nasdaq Capital Market and is now trading on the OTC Bulletin Board (OTCBB). Our common stock is deemed to be penny stock , which may make it more difficult for investors to sell their shares due to suitability requirements. We may issue a substantial amount of our common stock to holders of options and warrants and this could reduce the market price for our stock. Our common stock is thinly traded and a large percentage of our shares are held by a small group of unrelated, institutional owners.

Full 10-K form ▸

related documents
1043961--3/31/2006--TRANSGENOMIC_INC
1043961--3/28/2008--TRANSGENOMIC_INC
1043961--4/2/2007--TRANSGENOMIC_INC
225211--4/15/2009--MOBICLEAR_INC.
869986--6/29/2009--ADVANCED_PHOTONIX_INC
1102542--1/27/2006--SCO_GROUP_INC
889423--4/2/2007--SATCON_TECHNOLOGY_CORP
1118037--3/31/2009--MATHSTAR_INC
771999--3/29/2007--DOCUMENT_SECURITY_SYSTEMS_INC
878280--10/9/2007--SALTON_INC
102198--10/28/2008--COMPETITIVE_TECHNOLOGIES_INC
1095691--3/23/2009--DigitalFX_International_Inc
740726--4/3/2007--BROADCAST_INTERNATIONAL_INC
1174891--12/22/2008--UPSTREAM_BIOSCIENCES_INC.
1107216--5/24/2006--ORCHID_CELLMARK_INC
740726--3/30/2009--BROADCAST_INTERNATIONAL_INC
720762--10/29/2010--NON_INVASIVE_MONITORING_SYSTEMS_INC_/FL/
1115975--6/12/2009--SILVERGRAPH_INTERNATIONAL_INC
357108--1/12/2009--IRVINE_SENSORS_CORP/DE/
1094139--3/31/2010--OURPETS_CO
1063254--3/4/2008--S1_CORP_/DE/
1126983--10/13/2006--NEW_MEDIUM_ENTERPRISES_INC
867840--9/21/2010--PRECISION_OPTICS_CORPORATION_INC
867840--9/28/2009--PRECISION_OPTICS_CORPORATION_INC
802356--7/11/2007--PARLUX_FRAGRANCES_INC
849146--9/15/2010--Lifevantage_Corp
1063254--3/16/2006--S1_CORP_/DE/
867840--9/26/2008--PRECISION_OPTICS_CORPORATION_INC
1456453--4/29/2010--WellTek_Inc
1103345--3/15/2010--BEACON_POWER_CORP